Comparison of helical tomotherapy with multi-field intensity-modulated radiotherapy treatment plans using simultaneous integrated boost in high-risk prostate cancer

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30. https://doi.org/10.3322/caac.2159010.3322/caac.21590 Search in Google Scholar

2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancerstatistics 2018: GLOBOCAN estimates of incidence and mortality World wide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020;70(4):313.10.3322/caac.21492 Search in Google Scholar

3. Kuban DA, Tucker SL, Dong L, et al. Long-termresults of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67-74. https://doi.org/10.1016/j.ijrobp.2007.06.05410.1016/j.ijrobp.2007.06.054 Search in Google Scholar

4. Dearnaley DP, Jovic G, Syndikus I, et al. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2014;15(4):464-73. https://doi.org/10.1016/S1470-2045(14)70040-310.1016/S1470-2045(14)70040-3 Search in Google Scholar

5. Cilla S, Deodato F, Digesù C, Macchia G, Picardi V, Ferro M, Sallustio G, De Spirito M, Piermattei A, Morganti AG. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases. Med Dosim. 2014 Spring;39(1):108-16. https://doi.org/10.1016/j.meddos.2013.11.001. Epub 2013 Dec 15. PMID: 24342167.10.1016/j.meddos.2013.11.001 Search in Google Scholar

6. Saracino B, Petrongari MG, Marzi S, et al. Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control. Cancer Med. 2014;3(5):1313-1321. https://doi.org/10.1002/cam4.27810.1002/cam4.278 Search in Google Scholar

7. Pacelli R, Caroprese M, Palma G, et al. Technologicalevolution of radiationtreatment: Implications for clinical applications. Semin Oncol. 2019;46(3):193-201. https://doi.org/10.1053/j.seminoncol.2019.07.00410.1053/j.seminoncol.2019.07.004 Search in Google Scholar

8. Cuccia F, Mazzola R, Arcangeli S, et al. Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study. Tumori. 2019;105(6):516-523. https://doi.org/10.1177/030089161986784610.1177/0300891619867846 Search in Google Scholar

9. Morikawa LK, Roach M. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions. Int J Radiat Oncol Biol Phys. 2011;80(1):6-16. https://doi.org/10.1016/j.ijrobp.2010.11.07410.1016/j.ijrobp.2010.11.074 Search in Google Scholar

10. Lawton CA, Michalski J, El-Naqa I, et al. RTOG GU Radiation oncology specialists reachconsensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):383-7. https://doi.org/10.1016/j.ijrobp.2008.08.00210.1016/j.ijrobp.2008.08.002 Search in Google Scholar

11. Liang J, Wu Q, Yan D. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73(3):935-43. https://doi.org/10.1016/j.ijrobp.2008.10.01910.1016/j.ijrobp.2008.10.019 Search in Google Scholar

12. Ramiandrisoa F, Duvergé L, Castelli J, et al. Détermination des marges du volume cible anatomoclinique au volume cible prévisionnel pour la radiothérapie du cancer prostatique [Clinical to planning target volume margins in prostate cancer radiotherapy]. Cancer Radiother. 2016 Oct;20(6-7):629-39. French. https://doi.org/10.1016/j.canrad.2016.07.09510.1016/j.canrad.2016.07.095 Search in Google Scholar

13. Piotrowski T, Kaczmarek K, Bajon T, et al. Evaluation of image-guidance strategies for prostate cancer. Technol Cancer Res Treat. 2014;13(6):583-91. https://doi.org/10.7785/tcrtexpress.2013.60025810.7785/tcrtexpress.2013.600258 Search in Google Scholar

14. Gay HA, Barthold HJ, O’Meara E, et al. Pelvic normal tissue contouring guidelines for radiationtherapy: A RadiationTherapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012;83:e353-e362. https://doi.org/10.1016/j.ijrobp.2012.01.02310.1016/j.ijrobp.2012.01.023 Search in Google Scholar

15. International Commission on Radiation Units and Measurements Report 83. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU 2010;10(1). https://doi.org/10.1093/jicru/ndq00210.1093/jicru/ndq002 Search in Google Scholar

16. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury [published correction appears in Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1185]. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S123-S129. https://doi.org/10.1016/j.ijrobp.2009.03.07810.1016/j.ijrobp.2009.03.078 Search in Google Scholar

17. Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arctherapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D conformal RT for treatment of prostate cancer. Radiother Oncol 2009; 93:226-233. https://doi.org/10.1016/j.radonc.2009.08.01110.1016/j.radonc.2009.08.011 Search in Google Scholar

18. Shaw E, Kline R, Gillin M, et al. Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;27:1231-1239. https://doi.org/10.1016/0360-3016(93)90548-a10.1016/0360-3016(93)90548-A Search in Google Scholar

19. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64(2):333-42. https://doi.org/10.1016/j.ijrobp.2005.09.02810.1016/j.ijrobp.2005.09.028 Search in Google Scholar

20. Kataria T, Sharma K, Subramani V, et al. Homogeneity Index: An objective tool for assessment of conformal radiation treatments. J Med Phys. 2012;37(4):207-213. https://doi.org/10.4103/0971-6203.10360610.4103/0971-6203.103606 Search in Google Scholar

21. Ning ZH, Mu JM, Jin JX, et al. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol. 2013;8:237. https://doi.org/10.1186/1748-717X-8-23710.1186/1748-717X-8-237 Search in Google Scholar

22. Skórska M, Piotrowski T. Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients. Phys Med. 2013;29(3):273-85. https://doi.org/10.1016/j.ejmp.2012.03.00710.1016/j.ejmp.2012.03.007 Search in Google Scholar

23. Cao D, Holmes TW, Afghan MK, Shepard DM. Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;69(1):240-50. https://doi.org/10.1016/j.ijrobp.2007.04.07310.1016/j.ijrobp.2007.04.073 Search in Google Scholar

24. Tsai CL, Wu JK, Chao HL, et al. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim. 2011;36(3):264-71. https://doi.org/10.1016/j.meddos.2010.05.00110.1016/j.meddos.2010.05.001 Search in Google Scholar

25. Rong Y, Tang G, Welsh JS, et al. Helical tomotherapy versus single-arc intensity-modulated arctherapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys. 2011;81(1):284-96. https://doi.org/10.1016/j.ijrobp.2010.10.05910.1016/j.ijrobp.2010.10.059 Search in Google Scholar

26. Ishii K, Ogino R, Okada W, et al. A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol. 2013;86(1030):20130199. https://doi.org/10.1259/bjr.2013019910.1259/bjr.20130199 Search in Google Scholar

27. Davidson MT, Blake SJ, Batchelar DL, et al. Assessingthe role of volumetricmodulatedarctherapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys. 2011;80(5):1550-8. https://doi.org/10.1016/j.ijrobp.2010.10.02410.1016/j.ijrobp.2010.10.024 Search in Google Scholar

28. Pasquier D, Cavillon F, Lacornerie T, et al. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(2):549-554. https://doi.org/10.1016/j.ijrobp.2012.03.04610.1016/j.ijrobp.2012.03.046 Search in Google Scholar

29. Servagi-Vernat S, Giraud P, Fenoglietto P, et al. Apport de la RCMI rotationnelle et de la tomothérapiehélicoïdaledans les cancers pelviens : étudedosimétrique prospective sur 51 patients [Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients]. Cancer Radiother. 2014;18(2):111-118. https://doi.org/10.1016/j.canrad.2013.12.00810.1016/j.canrad.2013.12.008 Search in Google Scholar

30. Abu-Gheida I, Reddy CA, Kotecha R, et al. Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019;104(2):325-333. https://doi.org/10.1016/j.ijrobp.2019.01.09110.1016/j.ijrobp.2019.01.091 Search in Google Scholar

31. Widesott L, Pierelli A, Fiorino C, et al. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys. 2011;80(5):1589-1600. https://doi.org/10.1016/j.ijrobp.2010.10.00510.1016/j.ijrobp.2010.10.005 Search in Google Scholar

32. Barelkowski T, Wust P, Kaul D, et al. Image-guided dose-escalated radiation therapy for localized prostate cancer with helical tomotherapy. Strahlenther Onkol. 2020;196(3):229-242. https://doi.org/10.1007/s00066-019-01562-210.1007/s00066-019-01562-2 Search in Google Scholar

33. Beck M, Wust P, Barelkowski T, et al. Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy. Radiat Oncol. 2017;12(1):125. https://doi.org/10.1186/s13014-017-0862-410.1186/s13014-017-0862-4 Search in Google Scholar